Evidence item

Independent coverage reports the RIO antibody arm’s lower early rebound and much later median ART restart than placebo. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 16949

Source: Use of long-acting broadly neutralizing antibodies may delay HIV rebound following discontinuation of antiretroviral therapy · locator {} · excerpt hash sha256:8bea23dc2e70acd0adaf657ac09b9677be7c56befcacba2c672e4d34d69934f2

Early viral rebound before week 20 occurred in 8 participants in the bNAb group versus 30 in the placebo group ... Median time to ART restart was 45.4 weeks in the bNAb group compared with 4.6 weeks in the control group.